https://doi.org/10.18632/oncotarget.15053
O
Olga Fedorova
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
1.2K
Citations
22
h-index
34
i10-index
Olga Fedorova is an academic researcher from Institute of Cytology. The author has contributed to research in topics: Cancer-related Molecular Pathways & Epigenetics and DNA Methylation & Ubiquitin and proteasome pathways. The author has an h-index of 22, co-authored 70 publications.
ORCID: 0000-0003-1382-4204Papers by this author
worksOne-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
2017 · Oncotarget · 164 citations
The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell Death
2020 · Biochemistry (Moscow) · 15 citations
https://doi.org/10.1134/s0006297920100156
Dualistic role of ZEB1 and ZEB2 in tumor progression
2025 · Biology Direct · 10 citations
https://doi.org/10.1186/s13062-025-00604-3
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells
2020 · Cell Death Discovery · 7 citations
https://doi.org/10.1038/s41420-020-00336-5
T86
2015 · European Journal of Cancer Supplements · 1 citations
https://doi.org/10.1016/j.ejcsup.2015.08.006
Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.6818396
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat